Sarah Samreen, MBBS

Sarah Samreen practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Sarah Samreen's NPI, 1356780498, was assigned on June 21, 2013. Sarah Samreen graduated from Aga Khan Medical College in 2010. Sarah Samreen holds Texas license 46798.

Sarah Samreen's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Sarah Samreen's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Sarah Samreen practices. Vendor and product names are available with a free account.

Surgery is Sarah Samreen's primary specialty in the NPI Registry, under taxonomy code 208600000X. Sarah Samreen is board certified in surgery by the American Board of Surgery. Dmand AI has Sarah Samreen's licenses on file in 4 states: Texas, Nebraska, Pennsylvania and Massachusetts.

Dmand AI lists bariatric surgery, esophagus, stomach, or upper small intestine surgery, gallbladder removal, groin hernia surgery and upper GI endoscopy among the conditions Sarah Samreen treats.

CMS data shows 44 Medicare services from Sarah Samreen across 3 procedure codes in 2024, all of them office visits, for 53 Medicare patients. Medicare paid $2,483 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Sarah Samreen in 2024. The largest group is under 65, with 22 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sarah Samreen's median patient age at 64, with 73% women.

In 2024, Sarah Samreen wrote 64 Medicare Part D claims for 32 patients. 100% of them were for generic drugs. CMS names the drug for 37 of them, across 2 drugs with 11 or more claims each, at $552 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Sarah Samreen for performance year 2024, reported as part of a group. Sarah Samreen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Sarah Samreen, more than 42% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Sarah Samreen in 2024. 2024 was the busiest year, with 10. The most frequent topics are Postoperative Complications, Bariatric Surgery and Obesity, Morbid. Sarah Samreen has published most often in Surg Endosc. Sarah Samreen's most frequent co-authors are Patricia Sylla, MD, Yewande Rukayat Alimi, MD and Shaneeta Monique Johnson, MD.

CMS Open Payments shows 132 general payments to Sarah Samreen from 13 drug and device companies from 2017 to 2025. Education make up the largest share, 48% of the total. Intuitive Surgical, Inc. paid the most, $24,818.

Sarah Samreen graduated from Aga Khan Medical College in 2010. Sarah Samreen is a member of ACS and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).

Sarah Samreen is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.